These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7043155)

  • 1. The pathogenesis of non-insulin-dependent diabetes: an update.
    DeFronzo RA; Ferrannini E
    Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
    [No Abstract]   [Full Text] [Related]  

  • 2. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.
    DeFronzo RA; Ferrannini E; Koivisto V
    Am J Med; 1983 Jan; 74(1A):52-81. PubMed ID: 6337486
    [No Abstract]   [Full Text] [Related]  

  • 3. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 4. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary and secondary failure of sulphonylureas].
    Kanno H; Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation. Effect of prednisone.
    Ryan WG; Schwartz TB; Nibbe AF
    Diabetes; 1971 Jun; 20(6):410-5. PubMed ID: 4933891
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.
    Owens DR
    Am J Med; 1985 Aug; 79(2B):27-32. PubMed ID: 3929599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of the manifestation of diabetes mellitus through dietetic and drug measures. 1. Theoretical and clinical aspects with reference to the insulin findings in the peripheral venous blood].
    Wüstenberg PW; Werner P; Dannenberg C; Michaelis D
    Z Gesamte Inn Med; 1974 Mar; 29(6):221-7. PubMed ID: 4369652
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic changes in the islets of Langerhans in relationship to the onset of diabetes mellitus.
    Taylor KW
    Diabetologia; 1972 Aug; 8(4):236-43. PubMed ID: 4564647
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum insulin in early latent diabetes mellitus.
    Shochat G; Wilansky DL
    Metabolism; 1968 Oct; 17(10):928-35. PubMed ID: 4877989
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation.
    Ryan WG; Schwartz TB; Nibbe AF
    Diabetes; 1971 Jun; 20(6):404-9. PubMed ID: 4933890
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociation of the obesity-hyperinsulinism relationship following dietary restriction and hyperalimentation.
    Drenick EJ; Brickman AS; Gold EM
    Am J Clin Nutr; 1972 Aug; 25(8):746-55. PubMed ID: 4558367
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.
    Perseghin G; Mazzaferro V; Sereni LP; Regalia E; Benedini S; Bazzigaluppi E; Pulvirenti A; Leão AA; Calori G; Romito R; Baratti D; Luzi L
    Hepatology; 2000 Mar; 31(3):694-703. PubMed ID: 10706560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of hepatogenic diabetes mellitus].
    Ratzmann KP
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(5):361-70. PubMed ID: 4583562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial phases of diabetes mellitus].
    Baranov VG; Orkodashvili LSh
    Sov Med; 1973 Dec; 36(12):3-10. PubMed ID: 4591870
    [No Abstract]   [Full Text] [Related]  

  • 19. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 20. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].
    Mordkovskaia NM
    Probl Endokrinol (Mosk); 1971; 17(5):121-5. PubMed ID: 4337075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.